Baumert, Thomas F.

Publishing since 1998 (Senior)

Has published 58 publications in 13 years

Number of publications published per year by Baumert, Thomas F.. (Source : PubMed)

Distribution of publications types for Baumert, Thomas F.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Bankwitz D, Steinmann E, Bitzegeio J, Ciesek S, Friesland M, Hermann E, Zeisel MB, Baumert TF, Keck ZY, Foung SK, Pécheur EI, Pietschmann T. Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site and Protects Conserved Neutralizing Epitopes. J. Virol. 2010
Dhillon S, Witteveldt J, Gatherer D, Owsianka AM, Zeisel MB, Zahid MN, Rychlowska M, Foung SK, Baumert TF, Angus AG, Patel AH. Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies. J. Virol. 2010
Benga WJ, Krieger SE, Dimitrova M, Zeisel MB, Parnot M, Lupberger J, Hildt E, Luo G, McLauchlan J, Baumert TF, Schuster C. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 2010;51;1
Himmelsbach K, Sauter D, Baumert TF, Ludwig L, Blum HE, Hildt E. New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication. Gut 2009;58;12
Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, Mee C, Soulier E, Royer C, Lambotin M, Grunert F, Dao Thi VL, Dreux M, Cosset FL, McKeating JA, Schuster C, Baumert TF. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations. Hepatology 2009
Mello IM, Thumann C, Schvoerer E, Soulier E, Pinho JR, Silvestre DA, Queiroz AT, Wolf P, Baumert TF, Keller FS, Pereira CA. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation. J. Viral Hepat. 2009;16;10
Pfeffer S, Baumert TF. Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver. J. Hepatol. 2009;51;3
Eyre NS, Baumert TF, Beard MR. Closing the gap: the tight junction protein occludin and hepatitis C virus entry. Hepatology 2009;49;5
Weseslindtner L, Neumann-Haefelin C, Viazov S, Haberstroh A, Kletzmayr J, Aberle JH, Timm J, Ross SR, Klauser-Braun R, Baumert TF, Roggendorf M, Thimme R, Holzmann H. Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability. J. Hepatol. 2009;50;4
Vieyres G, Angus AG, Haberstroh A, Baumert TF, Dubuisson J, Patel AH. Rapid synchronization of hepatitis C virus infection by magnetic adsorption. J. Virol. Methods 2009;157;1

[ See timeline ] [ See all publications ]

h=31

means that Baumert, Thomas F. has 31 papers cited a least 31 times - methodology

Key figures

58 pub in 13 years
4.5 publications/year
best year 2009 with 12 pub
h-index 31 with 58 pub
h-ratio : 53 %

See Timeline

Ranking

It's me !

Click here if you are
Baumert, Thomas F..

Most frequent Journals

Hepatology (17x)
J. Virol. (12x)
J. Hepatol. (7x)
World J. Gastroenterol. (5x)
Proc. Natl. Acad. Sci. U.S.A. (3x)

Main affiliation

Inserm U748, Université de Strasbourg, Strasbourg, France

Latest co-workers

Bartenschlager R Barth H Blum HE Cosset FL Doffoel M Fafi-Kremer S Haberstroh A Hildt E Hu Z Liang TJ Patel AH Royer C Schnober EK Schuster C Schvoerer E Soulier E Stoll-Keller F Thumann C Wolf P Zeisel MB

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.